Nicotine Immunization
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Larry Kaskel is joined by Dr. Frank Vocci, Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse at the NIH. He will discuss NicVAX, an anti-smoking vaccine that keeps nicotine molecules from ever entering or affecting the brain. Tune in to find out how it works. And, more importantly, will it work?
Overview
Dr. Larry Kaskel is joined by Dr. Frank Vocci, Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse at the NIH. He will discuss NicVAX, an anti-smoking vaccine that keeps nicotine molecules from ever entering or affecting the brain. Tune in to find out how it works. And, more importantly, will it work?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Evolving Our View of the Coagulation Cascade and Stroke Management
M3: Managing the Cardiometabolic Risk in MASH
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Love Story: Lipid Education for Women’s Heart Health
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
HF Management for Patients with Comorbid Conditions
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?